SHW
65
9
NEE
50
3
GS
52
-7
CMG
57
-6
KR
38
-2
BSX
61
2
SYY
44
-8
WFC
66
-5
MMC
57
4
JWN
52
2
LEG
28
6
AMG
22
-16
ZBH
59
2
XRX
30
2
BIIB
37
9
MTCH
50
19
ADI
47
-2
BLK
66
2
FCX
65
6
MU
35
3
SHW
65
9
NEE
50
3
GS
52
-7
CMG
57
-6
KR
38
-2
BSX
61
2
SYY
44
-8
WFC
66
-5
MMC
57
4
JWN
52
2
LEG
28
6
AMG
22
-16
ZBH
59
2
XRX
30
2
BIIB
37
9
MTCH
50
19
ADI
47
-2
BLK
66
2
FCX
65
6
MU
35
3
Financhill
Back

Marinus Pharmaceuticals Vs. Cellectar Biosciences Industry Stock Comparison

Sell
31

MRNS
Marinus Pharmaceuticals

Last Price:
0.34
Seasonality Move:
12.73%
Sell
38

CLRB
Cellectar Biosciences

Last Price:
2.04
Seasonality Move:
-1.23%
Sell
31
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $0.34. The Score for MRNS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.03. The Score for CLRB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 23.83 Sell
Chaikin Money Flow: 1451987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.64 - 1.96) Sell
Bollinger Bands (100): (1 - 1.72) Sell

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.93 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.04 - 2.14) Sell
Bollinger Bands (100): (1.93 - 2.57) Sell

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.33 Buy
20-day SMA: 1.19 Sell
50-day SMA: 1.41 Sell
200-day SMA: 3.73 Sell
8-day EMA: 0.52 Sell
20-day EMA: 0.96 Sell
50-day EMA: 1.29 Sell
200-day EMA: 3.12 Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.05 Sell
20-day SMA: 2.07 Sell
50-day SMA: 2.09 Sell
200-day SMA: 2.87 Sell
8-day EMA: 2.05 Sell
20-day EMA: 2.06 Sell
50-day EMA: 2.12 Sell
200-day EMA: 2.51 Sell

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):